Results 31 to 40 of about 2,498 (139)

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model

open access: yesBiomedicines, 2020
Current therapeutic medicines for endometriosis cannot be administered during assisted reproductive technology (ART) because they have bad effects during pregnancy.
Young Sang Kim   +5 more
doaj   +1 more source

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy

open access: yesESC Heart Failure, 2023
Aims Peripartum cardiomyopathy (PPCM) is a rare heart disease, occurring in previously heart‐healthy women during the last month of pregnancy or the first months after delivery due to left ventricular (LV) systolic dysfunction.
Tobias J. Pfeffer   +12 more
doaj   +1 more source

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson   +13 more
wiley   +1 more source

Cabergoline Decreases Alcohol Drinking and Seeking Behaviors Via Glial Cell Line-Derived Neurotrophic Factor

open access: yes, 2009
Background: Cabergoline is an ergotamine derivative that increases the expression of glial cell line-derived neurotrophic factor (GDNF) in vitro. We recently showed that GDNF in the ventral tegmental area (VTA) reduces the motivation to consume alcohol ...
Ahmadiantehrani, S.   +6 more
core   +1 more source

Effect of Cabergoline Treatment on Disease Control in Acromegaly Patients.

open access: yes, 2022
The aim of this study was to evaluate the efficacy of cabergoline in normalizing plasma IGF-I levels in acromegaly patients with elevated IGF-I levels after surgery and/or SRL therapy. Acromegaly patients (n: 143) were evaluated retrospectively. Patients
Gul, Nurdan   +7 more
core   +1 more source

Hypogonadotropic Hypogonadism Before and After Transsphenoidal Surgery for Non‐Functioning Pituitary Adenoma

open access: yesClinical Endocrinology, Volume 105, Issue 4, Page 442-451, October 2026.
ABSTRACT Objective The effect of transsphenoidal surgery (TSS) on the hypothalamic‐pituitary‐gonadal (HPG) axis in patients with non‐functioning pituitary adenomas (NFPA) is underexplored, especially in women. Our aim was to investigate the HPG axis function before and after TSS, its association with quality of life (QoL), and to identify factors that ...
Victor Hantelius   +6 more
wiley   +1 more source

Multivessel spontaneous coronary artery dissection in a young woman using cabergoline

open access: yesEndocrinology, Diabetes & Metabolism Case Reports
We present a unique case of multivessel spontaneous coronary artery dissection (SCAD) in a young woman using cabergoline. This woman presented with an acute coronary syndrome (ACS) on a background of cabergoline use for a prolactinoma diagnosed over 20 ...
Rachel Byrne, Paul Shiels, Rajesh Kumar
doaj   +1 more source

Impact of Osilodrostat on Health‐Related Quality of Life in Cushing's Disease: Analysis of Patient‐Reported Outcomes From the Phase III LINC 3 and LINC 4 Clinical Trials

open access: yesClinical Endocrinology, Volume 105, Issue 4, Page 452-463, October 2026.
ABSTRACT Objective Evaluate the effects of osilodrostat short‐ and long‐term treatment on health‐related quality of life (HRQoL) in Cushing's disease. Design LINC 3 and LINC 4 studies (pooled analysis). Patients 185 patients (mean baseline total scores: Cushing's Quality of Life [CushingQoL], 44.0; Beck Depression Inventory II [BDI‐II], 15.6; EuroQol ...
John Newell‐Price   +6 more
wiley   +1 more source

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting

open access: yes, 2013
The use of cabergoline and coasting are both effective in reducing the risk of ovarian hyperstimulation syndrome (OHSS).
BOZDAĞ, GÜRKAN   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy